Evaluating the immunogenicity of an intranasal vaccine against nicotine in mice using the Adjuvant Finlay Proteoliposome (AFPL1)

Tobacco smoking is recognized as a global pandemic resulting in 6 million deaths per year. Despite a variety of anti-smoking products available to aid with tobacco cessation, the majority of people who attempt to quit smoking relapse within 6 months due to the addictive nature of nicotine. An immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Fraleigh, Nya L., Boudreau, Justin, Bhardwaj, Nitin, Eng, Nelson F., Murad, Yanal, Lafrenie, Robert, Acevedo, Reinaldo, Oliva, Reynaldo, Diaz-Mitoma, Francisco, Le, Hoang-Thanh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008958/
https://www.ncbi.nlm.nih.gov/pubmed/27622215
http://dx.doi.org/10.1016/j.heliyon.2016.e00147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008958/
https://www.ncbi.nlm.nih.gov/pubmed/27622215
http://dx.doi.org/10.1016/j.heliyon.2016.e00147

Ejemplares similares